Webinar | Is your natural food dye compliant, shelf-stable, and ready to scale?
24th July | 12 PM ET: Register Now

SwiftPharma

SwiftPharma develops plant-based biomanufacturing solutions for animal-free proteins, vaccines, antibodies and biosimilars.
2021
11 – 50
Genk, Limburg, Belgium

Investment Funding

Revenue

$1M to $10M

Something missing or incorrect on this page? Help us enrich this information